Lee D. Arnold - 01 Feb 2023 Form 4 Insider Report for AETHLON MEDICAL INC (AEMD)

Role
Chief Scientific Officer
Signature
/s/ Lee D. Arnold
Issuer symbol
AEMD
Transactions as of
01 Feb 2023
Net transactions value
$0
Form type
4
Filing time
02 Feb 2023, 15:14:07 UTC
Previous filing
02 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEMD Employee Stock Option (Right to Buy) Award $0 +60,620 $0.000000 60,620 01 Feb 2023 Common Stock 60,620 $0.6900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the stock option shall vest and become exercisable on February 1, 2024, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter.